The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment

The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2015-11, Vol.1 (10), p.e1500845-e1500845
Hauptverfasser: Sharma, Madhav D, Shinde, Rahul, McGaha, Tracy L, Huang, Lei, Holmgaard, Rikke B, Wolchok, Jedd D, Mautino, Mario R, Celis, Esteban, Sharpe, Arlene H, Francisco, Loise M, Powell, Jonathan D, Yagita, Hideo, Mellor, Andrew L, Blazar, Bruce R, Munn, David H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e1500845
container_issue 10
container_start_page e1500845
container_title Science advances
container_volume 1
creator Sharma, Madhav D
Shinde, Rahul
McGaha, Tracy L
Huang, Lei
Holmgaard, Rikke B
Wolchok, Jedd D
Mautino, Mario R
Celis, Esteban
Sharpe, Arlene H
Francisco, Loise M
Powell, Jonathan D
Yagita, Hideo
Mellor, Andrew L
Blazar, Bruce R
Munn, David H
description The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.
doi_str_mv 10.1126/sciadv.1500845
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1749601164</sourcerecordid><originalsourceid>FETCH-LOGICAL-p181t-b7917fbf644689e93642a32a1657600b54e2b4ee0efa7d114a7da2f7a94dbd513</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbKm9epQ9emnd3exukosgpX5AUQ8RvIVJMmlXkmzcTSL990asopeZYT6ed3gJOedsybnQVz43UAxLrhiLpDoiUxGEaiGUjI7_1BMy9_6NMcal1orHp2QitGacSzElr8kO6XOyfqQtdLsP2FPT0MTh1lPjKdDcmc7kUNHCmQEdtSXtxgvft61D78ce7fraOlqb3FlsBuNsU2PTnZGTEiqP80OekZfbdbK6X2ye7h5WN5tFyyPeLbIw5mGZlVpKHcUYB1oKCARwrULNWKYkikwiMiwhLMafxwiiDCGWRVYoHszI9Te37bMai3yUdlClrTM1uH1qwaT_J43ZpVs7pFJLpmIxAi4PAGffe_RdWhufY1VBg7b3KQ9l_OWWluPqxV-tX5EfO4NP0-R6Jw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1749601164</pqid></control><display><type>article</type><title>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sharma, Madhav D ; Shinde, Rahul ; McGaha, Tracy L ; Huang, Lei ; Holmgaard, Rikke B ; Wolchok, Jedd D ; Mautino, Mario R ; Celis, Esteban ; Sharpe, Arlene H ; Francisco, Loise M ; Powell, Jonathan D ; Yagita, Hideo ; Mellor, Andrew L ; Blazar, Bruce R ; Munn, David H</creator><creatorcontrib>Sharma, Madhav D ; Shinde, Rahul ; McGaha, Tracy L ; Huang, Lei ; Holmgaard, Rikke B ; Wolchok, Jedd D ; Mautino, Mario R ; Celis, Esteban ; Sharpe, Arlene H ; Francisco, Loise M ; Powell, Jonathan D ; Yagita, Hideo ; Mellor, Andrew L ; Blazar, Bruce R ; Munn, David H</creatorcontrib><description>The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.</description><identifier>ISSN: 2375-2548</identifier><identifier>EISSN: 2375-2548</identifier><identifier>DOI: 10.1126/sciadv.1500845</identifier><identifier>PMID: 26601142</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Cancer Immunotherapy ; SciAdv r-articles</subject><ispartof>Science advances, 2015-11, Vol.1 (10), p.e1500845-e1500845</ispartof><rights>Copyright © 2015, The Authors 2015 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640592/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640592/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26601142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharma, Madhav D</creatorcontrib><creatorcontrib>Shinde, Rahul</creatorcontrib><creatorcontrib>McGaha, Tracy L</creatorcontrib><creatorcontrib>Huang, Lei</creatorcontrib><creatorcontrib>Holmgaard, Rikke B</creatorcontrib><creatorcontrib>Wolchok, Jedd D</creatorcontrib><creatorcontrib>Mautino, Mario R</creatorcontrib><creatorcontrib>Celis, Esteban</creatorcontrib><creatorcontrib>Sharpe, Arlene H</creatorcontrib><creatorcontrib>Francisco, Loise M</creatorcontrib><creatorcontrib>Powell, Jonathan D</creatorcontrib><creatorcontrib>Yagita, Hideo</creatorcontrib><creatorcontrib>Mellor, Andrew L</creatorcontrib><creatorcontrib>Blazar, Bruce R</creatorcontrib><creatorcontrib>Munn, David H</creatorcontrib><title>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</title><title>Science advances</title><addtitle>Sci Adv</addtitle><description>The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.</description><subject>Cancer Immunotherapy</subject><subject>SciAdv r-articles</subject><issn>2375-2548</issn><issn>2375-2548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdRbKm9epQ9emnd3exukosgpX5AUQ8RvIVJMmlXkmzcTSL990asopeZYT6ed3gJOedsybnQVz43UAxLrhiLpDoiUxGEaiGUjI7_1BMy9_6NMcal1orHp2QitGacSzElr8kO6XOyfqQtdLsP2FPT0MTh1lPjKdDcmc7kUNHCmQEdtSXtxgvft61D78ce7fraOlqb3FlsBuNsU2PTnZGTEiqP80OekZfbdbK6X2ye7h5WN5tFyyPeLbIw5mGZlVpKHcUYB1oKCARwrULNWKYkikwiMiwhLMafxwiiDCGWRVYoHszI9Te37bMai3yUdlClrTM1uH1qwaT_J43ZpVs7pFJLpmIxAi4PAGffe_RdWhufY1VBg7b3KQ9l_OWWluPqxV-tX5EfO4NP0-R6Jw</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Sharma, Madhav D</creator><creator>Shinde, Rahul</creator><creator>McGaha, Tracy L</creator><creator>Huang, Lei</creator><creator>Holmgaard, Rikke B</creator><creator>Wolchok, Jedd D</creator><creator>Mautino, Mario R</creator><creator>Celis, Esteban</creator><creator>Sharpe, Arlene H</creator><creator>Francisco, Loise M</creator><creator>Powell, Jonathan D</creator><creator>Yagita, Hideo</creator><creator>Mellor, Andrew L</creator><creator>Blazar, Bruce R</creator><creator>Munn, David H</creator><general>American Association for the Advancement of Science</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151101</creationdate><title>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</title><author>Sharma, Madhav D ; Shinde, Rahul ; McGaha, Tracy L ; Huang, Lei ; Holmgaard, Rikke B ; Wolchok, Jedd D ; Mautino, Mario R ; Celis, Esteban ; Sharpe, Arlene H ; Francisco, Loise M ; Powell, Jonathan D ; Yagita, Hideo ; Mellor, Andrew L ; Blazar, Bruce R ; Munn, David H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p181t-b7917fbf644689e93642a32a1657600b54e2b4ee0efa7d114a7da2f7a94dbd513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cancer Immunotherapy</topic><topic>SciAdv r-articles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharma, Madhav D</creatorcontrib><creatorcontrib>Shinde, Rahul</creatorcontrib><creatorcontrib>McGaha, Tracy L</creatorcontrib><creatorcontrib>Huang, Lei</creatorcontrib><creatorcontrib>Holmgaard, Rikke B</creatorcontrib><creatorcontrib>Wolchok, Jedd D</creatorcontrib><creatorcontrib>Mautino, Mario R</creatorcontrib><creatorcontrib>Celis, Esteban</creatorcontrib><creatorcontrib>Sharpe, Arlene H</creatorcontrib><creatorcontrib>Francisco, Loise M</creatorcontrib><creatorcontrib>Powell, Jonathan D</creatorcontrib><creatorcontrib>Yagita, Hideo</creatorcontrib><creatorcontrib>Mellor, Andrew L</creatorcontrib><creatorcontrib>Blazar, Bruce R</creatorcontrib><creatorcontrib>Munn, David H</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharma, Madhav D</au><au>Shinde, Rahul</au><au>McGaha, Tracy L</au><au>Huang, Lei</au><au>Holmgaard, Rikke B</au><au>Wolchok, Jedd D</au><au>Mautino, Mario R</au><au>Celis, Esteban</au><au>Sharpe, Arlene H</au><au>Francisco, Loise M</au><au>Powell, Jonathan D</au><au>Yagita, Hideo</au><au>Mellor, Andrew L</au><au>Blazar, Bruce R</au><au>Munn, David H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment</atitle><jtitle>Science advances</jtitle><addtitle>Sci Adv</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>1</volume><issue>10</issue><spage>e1500845</spage><epage>e1500845</epage><pages>e1500845-e1500845</pages><issn>2375-2548</issn><eissn>2375-2548</eissn><abstract>The tumor microenvironment is profoundly immunosuppressive. We show that multiple tumor types create intratumoral immune suppression driven by a specialized form of regulatory T cell (Treg) activation dependent on the PTEN (phosphatase and tensin homolog) lipid phosphatase. PTEN acted to stabilize Tregs in tumors, preventing them from reprogramming into inflammatory effector cells. In mice with a Treg-specific deletion of PTEN, tumors grew slowly, were inflamed, and could not create an immunosuppressive tumor microenvironment. In normal mice, exposure to apoptotic tumor cells rapidly elicited PTEN-expressing Tregs, and PTEN-deficient mice were unable to maintain tolerance to apoptotic cells. In wild-type mice with large established tumors, pharmacologic inhibition of PTEN after chemotherapy or immunotherapy profoundly reconfigured the tumor microenvironment, changing it from a suppressive to an inflammatory milieu, and tumors underwent rapid regression. Thus, the immunosuppressive milieu in tumors must be actively maintained, and tumors become susceptible to immune attack if the PTEN pathway in Tregs is disrupted.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>26601142</pmid><doi>10.1126/sciadv.1500845</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2375-2548
ispartof Science advances, 2015-11, Vol.1 (10), p.e1500845-e1500845
issn 2375-2548
2375-2548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4640592
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Cancer Immunotherapy
SciAdv r-articles
title The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T23%3A08%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20PTEN%20pathway%20in%20Tregs%20is%20a%20critical%20driver%20of%20the%20suppressive%20tumor%20microenvironment&rft.jtitle=Science%20advances&rft.au=Sharma,%20Madhav%20D&rft.date=2015-11-01&rft.volume=1&rft.issue=10&rft.spage=e1500845&rft.epage=e1500845&rft.pages=e1500845-e1500845&rft.issn=2375-2548&rft.eissn=2375-2548&rft_id=info:doi/10.1126/sciadv.1500845&rft_dat=%3Cproquest_pubme%3E1749601164%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1749601164&rft_id=info:pmid/26601142&rfr_iscdi=true